A comprehensive examination of CYP19 variation and risk of breast cancer using two haplotype-tagging approaches
- 27 September 2006
- journal article
- research article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 102 (2) , 237-247
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Adjuvant Endocrine Therapy for Postmenopausal Women with Early Breast CancerClinical Cancer Research, 2006
- Estrogen Carcinogenesis in Breast CancerNew England Journal of Medicine, 2006
- Human Aromatase: Gene Resequencing and Functional GenomicsCancer Research, 2005
- High‐throughput multiplex single‐nucleotide polymorphism analysis for red cell and platelet antigen genotypesTransfusion, 2005
- CYP1B1 and CYP19 gene polymorphisms and breast cancer incidence: no association in the ARIC studyCancer Letters, 2004
- Score Tests for Association between Traits and Haplotypes when Linkage Phase Is AmbiguousThe American Journal of Human Genetics, 2002
- A tetranucleotide repeat polymorphism inCYP19 and breast cancer riskInternational Journal of Cancer, 2000
- Genetic variants of CYP19 (aromatase) and breast cancer riskOncogene, 2000
- A rare CYP19 (aromatase) variant may increase the risk of breast cancerPharmacogenetics, 1998
- Tests for Linear Trends in Proportions and Frequencies1955